“The unique fusion of individual innovative technologies will provide a novel diagnostic tool leading to a better understanding of the underlying pathophysiology of rare anaemia.”

Lars Kaestner, Coordinator of CoMMiTMenT

Making a difference in Rare Anaemia

CoMMiTMenT is a five-year Collaborative Project funded by the European Commission under the 7th Framework Programme of the European Union. The project aims to develop combined imaging technologies based on optofluidic microscopy and scanning ion conductance microscopy. An integrated, completely simultaneous device named µCOSMOS will be used as a proof-of-principle for therapeutic interventions in rare anaemias. Therefore, CoMMiTMenT contributes to the goal of the International Rare Diseases Research Consortium (IRDiRC) to deliver novel diagnostic modalities and 200 new therapies for rare diseases by 2020.

The CoMMiTMenT consortium combines outstanding expertise from successfully operating, research-intensive SMEs and leading academic institutions. In addition, the consortium includes clinical partners and builds a strong relationship with the European Network for Rare and Congenital Anaemias (ENERCA).


Looking for publications?

Latest news

Upcoming events